Literature DB >> 14645241

Interactions between activating signal cointegrator-2 and the tumor suppressor retinoblastoma in androgen receptor transactivation.

Young-Hwa Goo1, Soon-Young Na, Hao Zhang, Jianming Xu, SunHwa Hong, JaeHun Cheong, Soo-Kyung Lee, Jae Woon Lee.   

Abstract

Activating signal cointegrator-2 (ASC-2), a cancer-amplified transcription coactivator of nuclear receptors and numerous other transcription factors, was previously shown to contain two LXXLL motifs, each of which interacts with a distinct set of nuclear receptors. In this work, we showed that ASC-2 has an indirect, separate binding site for androgen receptor (AR). Interestingly, this region overlapped with the direct interaction interfaces with the tumor suppressor retinoblastoma (Rb). Although ASC-2 alone stimulated AR transactivation in cotransfections of HeLa cells, ectopic expression of Rb effected ASC-2 to act as a transcription coactivator of AR in Rb-null Saos2 cells. These results, along with the previous report in which AR was shown to directly interact with Rb (Yeh, S., Miyamoto, H., Nishimura, K., Kang, H., Ludlow, J., Hsiao, P., Wang, C., Su, C., and Chang C. (1998) Biochem. Biophys. Res. Commun. 248, 361-367), suggest that the AR-ASC-2 interactions in vivo may involve Rb. Thus, ASC-2 appears to contain at least three distinct nuclear receptor interaction domains.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645241     DOI: 10.1074/jbc.M312563200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Roles of histone H3-lysine 4 methyltransferase complexes in NR-mediated gene transcription.

Authors:  Seunghee Lee; Robert G Roeder; Jae W Lee
Journal:  Prog Mol Biol Transl Sci       Date:  2009-10-07       Impact factor: 3.622

Review 2.  Nuclear Receptor Coregulators in Hormone-Dependent Cancers.

Authors:  Hedieh Jafari; Shahid Hussain; Moray J Campbell
Journal:  Cancers (Basel)       Date:  2022-05-13       Impact factor: 6.575

3.  Crystal structure of the retinoblastoma protein N domain provides insight into tumor suppression, ligand interaction, and holoprotein architecture.

Authors:  Markus Hassler; Shradha Singh; Wyatt W Yue; Maciej Luczynski; Rachid Lakbir; Francisco Sanchez-Sanchez; Thomas Bader; Laurence H Pearl; Sibylle Mittnacht
Journal:  Mol Cell       Date:  2007-11-09       Impact factor: 17.970

4.  The transcriptional co-activator NCOA6 promotes estrogen-induced GREB1 transcription by recruiting ERα and enhancing enhancer-promoter interactions.

Authors:  Zhangwei Tong; Yonghong Liu; Xiaobin Yu; Jarrod D Martinez; Jianming Xu
Journal:  J Biol Chem       Date:  2019-11-19       Impact factor: 5.157

5.  Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation.

Authors:  Seunghee Lee; Dae-Hwan Kim; Young Hwa Goo; Young Chul Lee; Soo-Kyung Lee; Jae W Lee
Journal:  Mol Endocrinol       Date:  2009-02-12

6.  ASCOM controls farnesoid X receptor transactivation through its associated histone H3 lysine 4 methyltransferase activity.

Authors:  Dae-Hwan Kim; Jeongkyung Lee; Bora Lee; Jae W Lee
Journal:  Mol Endocrinol       Date:  2009-06-25

7.  Structural insights into the mechanism of phosphoregulation of the retinoblastoma protein.

Authors:  Ekaterina P Lamber; Fabienne Beuron; Edward P Morris; Dmitri I Svergun; Sibylle Mittnacht
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

Review 8.  Nuclear receptor coactivator/coregulator NCoA6(NRC) is a pleiotropic coregulator involved in transcription, cell survival, growth and development.

Authors:  Muktar A Mahajan; Herbert H Samuels
Journal:  Nucl Recept Signal       Date:  2008-02-01

9.  The N-terminal domain of the Drosophila retinoblastoma protein Rbf1 interacts with ORC and associates with chromatin in an E2F independent manner.

Authors:  Joseph Ahlander; Xiao-Bo Chen; Giovanni Bosco
Journal:  PLoS One       Date:  2008-07-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.